Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation
Summary: Health Technology Assessment (HTA) for reimbursement of all new cancer drugs in the European Union (EU) will be evaluated for all member states by a central European HTA starting in 2025. EU HTA guidelines for applicants under these new regulations put the focus on meta-analysis of aggregat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | The Lancet Regional Health. Europe |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666776225000869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|